Archive for the ‘Pharma Industry / Biotech Industry’ Category

LAB Research To Host Safety Pharmacology Seminar In Madison, WI

Wednesday, August 13th, 2008

LAB Research Inc. ("LRI" or "LAB Research") (TSX: LRI), a rapidly growing global non-clinical contract research organization, announced that it will host an exhibitor's seminar titled "Study Design in Safety Pharmacology: Emerging Trends in Drug Development" at the upcoming 2008 Safety Pharmacology Society Meeting in Madison, WI. The informative ...

Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)

Wednesday, August 13th, 2008

Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) and its co-development partner Astellas Pharma US, Inc. ("Astellas") announced that they have received an action letter dated August 8, 2008 from the U.S. Food and ...

Mylan Signs Deal With Indian Firm To Develop 22 Oral Contraceptives

Tuesday, August 12th, 2008

Mylan on Wednesday announced a deal with Indian drug maker Famy Care to develop and sell 22 generic oral contraceptive products, the Pittsburgh Tribune-Review reports (Stouffer, Pittsburgh Tribune-Review, 8/7). Mylan plans to seek FDA approval for the products over the next few months and hopes to begin marketing them in ...

Kucinich Introduces Legislation That Seeks To Lower Prescription Drug Costs By Replacing Medicare Part D

Tuesday, August 12th, 2008

Rep. Dennis Kucinich (D-Ohio) recently introduced a bill (HR 6800) that would replace the Medicare prescription drug benefit with a new program in an effort to reduce costs, CQ HealthBeat reports. The legislation would require Medicare to negotiate directly with pharmaceutical companies for discounts on prescription drugs and ...

PSA Supports NDPSC Decision On Ibuprofen-Codeine Products

Tuesday, August 12th, 2008

The Pharmaceutical Society of Australia (PSA) supports the National Drugs and Poisons Schedule Committee (NDPSC) decision to maintain the current scheduling status for ibuprofen-codeine combination pain-relief products while it considers potential limits to pack sizes. The NDPSC publicly released the results of decisions made at its June meeting. The ...

2nd Annual Digital Pharma; On The Cutting Edge Of Integrating New Media And New Marketing, Focus On Regulatory Issues. Oct 14-16

Monday, August 11th, 2008

ExL Pharma announces the 2nd Annual Digital Pharma Conference for marketers to discuss and learn about the very latest in applying technology to improve communications with key stakeholders. October 14-16, 2008 at the Westin Princeton in Princeton, NJ. For full details, go to: the event page (http://www.exlpharma.com/eventDetail.php?id=138)When Registering, ...

GTCbio Announces Largest Annual Conference - The 4th Modern Drug Discovery & Development Summit - Oct 15-17, 2008, San Diego

Monday, August 11th, 2008

GTCbio just announced the scheduling of one of the largest industry conferences taking place on October 15-17, 2008 in San Diego, CA. The 4th Modern Drug Discovery & Development features six full conferences, three symposia, six stand-alone sessions, and a plenary keynote session presenting some of the leaders in the ...

Bayer Files Patent Infringement Lawsuit Against Sandoz Related To Oral Contraceptive YAZ

Saturday, August 9th, 2008

Bayer officials on Tuesday announced that the company has filed a patent infringement lawsuit against Sandoz, the generic medication division of Novartis, related to the oral contraceptive YAZ, Reuters reports.Bayer has U.S. patent protection for YAZ, a lower-dose version of the oral contraceptive Yasmin, until March 2009. Sandoz has filed ...

GTCbio Announces Its Biomarker Discovery Europe Conference On October 2-3, 2008 In Dublin, Ireland

Saturday, August 9th, 2008

GTCbio just announced the 3rd edition of its Biomarker Series - the Biomarker Discovery Europe Conference - taking place on October 2-3, 2008 in Dublin, Ireland. Over the last several years, biomarkers have been an increasingly important and a heavily researched topic at all of the leading pharmaceutical and biotech ...

Big Changes In Public Attitudes Toward Different Industries Since Last Year

Saturday, August 9th, 2008

Every year at this time, The Harris Poll® measures public attitudes about 20 different industries. Specifically, we ask whether each industry is generally doing a good or a bad job of serving consumers. This year's survey finds many big changes, up and down, since last year. These are some of ...

Boehringer Ingelheim Continues To Post Strong Growth

Friday, August 8th, 2008

The pharmaceutical company Boehringer Ingelheim continued to post strong growth in local currencies in the first half of 2008 (+9.0%). On account of the strength of the euro against the US dollar and the Japanese yen, growth after consolidation in euro was +2.1% with net sales of EUR 5,522 million ...

Congress Considering Legislation That Would Create Academic Detailing Program For Prescription Drugs

Friday, August 8th, 2008

Legislation (HR 6752, S 3396) recently introduced in the House and Senate would create a program to provide physicians with unbiased information about prescription drugs, CQ HealthBeat reports. The so-called "academic detailing" program is part of an effort by lawmakers to change the relationship between physicians and the pharmaceutical industry, ...

Frost & Sullivan Honours TransPharma Medical For Its Innovative ViaDerm Drug Delivery System

Monday, August 4th, 2008

The 2008 Frost & Sullivan European Transdermal Drug Delivery Product Innovation Award is conferred on Israel-based TransPharma Medical Ltd. in recognition of its innovative ViaDerm drug delivery system. The company's two flagship drug product development programs - ViaDerm hPTH (1-34) for the treatment of osteoporosis and ViaDerm-hGH for the treatment ...

Senate, House Members Introduce Bill To Provide Doctors With Unbiased Information About Prescription Drugs, USA

Monday, August 4th, 2008

U.S. Senate Special Committee on Aging Chairman Herb Kohl (D-WI), Senate Majority Whip Dick Durbin (D-IL), and Senate Committee on Health, Education, Labor, and Pensions (HELP) Committee Chairman Ted Kennedy (D-MA), and Senator Bob Casey (D-PA) were joined by House Committee on Oversight and Government Reform Chairman Henry Waxman (D-CA) ...

Accelerated R&D Credit In House-Passed Housing Package Will Enhance Biotech Innovation, Speed Therapeutic Discovery And Increase Jobs

Sunday, August 3rd, 2008

Hundreds of biotechnology start-ups will be encouraged to utilize an incentive for capital investments as a result of a provision included in the Housing Bill passed by the U.S. House of Representatives last night by a vote of 272 - 152. "Many biotech companies whose products have not ...